🔴 Liquidia Technologies is trading at 6.5% down today after ruling found Yutrepia infringes patent claims

Liquidia Technologies is trading 6.51% down at $26.77 after a September 30 Delaware ruling found Yutrepia infringes two valid United Therapeutics patent claims for PH-ILD.

• Reuters reported Liquidia plans to pursue appellate options and ask the FDA to remove the PH-ILD indication from Yutrepia’s label.
• The court gave parties a week to submit a proposed judgment, including remedies; restrictions remain unresolved. The move extends the sharp repricing; broad-market context shows no same-direction index decline above 0.5%.